SEP
IBBQ icon

Signature Equity Partners’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Signature Equity Partners’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Buy
654
+1
+0.2% +$30 0.01% 632
2026
Q1 		$18.9K Sell
653
-1,177
-64% -$34.3K 0.01% 648
2025
Q4 		$52K Buy
+1,830
New +$49.8K 0.03% 392

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Signature Equity Partners's IBBQ Position: Q2 2026 in Review

Signature Equity Partners increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 0.15% in Q2 2026, buying an estimated $30 and bringing the position to 654 shares worth $21.3K. The position accounts for 0.01% of the portfolio, ranked #632.

Signature Equity Partners first reported a position in IBBQ in Q4 2025 and has held it in 3 quarters since. The position peaked at $52K in Q4 2025. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Signature Equity Partners held 654 shares of Invesco NASDAQ Biotechnology ETF worth $21.3K as of Q2 2026.
  • Signature Equity Partners bought 1 Invesco NASDAQ Biotechnology ETF share in Q2 2026, an estimated $30.
  • Invesco NASDAQ Biotechnology ETF made up 0.01% of Signature Equity Partners's portfolio in Q2 2026, its #632 holding.
  • Signature Equity Partners first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Invesco NASDAQ Biotechnology ETF position peaked at $52K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.